It has been reported that oligodeoxynucleotides targeting TLR9 oppositely modulate DNA repair genes in tumor versus immune cells and enhance the antitumor activity of DNA-damaging chemotherapy and radiation therapy in preclinical mouse models [46]. Here, TLR9 is linked to neoplasm.